Sponsor Pipeline

Gila Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-27 NCT07728383 A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity Phase 4 Recruiting
Active Trials by Phase
Phase 4
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07728383 A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity Obesity & Overweight Recruiting
Disease Areas
Obesity (1)
Get alerts when Gila Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free